Bibliographic information
GuidelineWHO consolidated guidelines on drug-resistant tuberculosis treatment
Year of Publication2019
Issuing InstitutionWorld Health Organization
Recommendation
Maintained
The following treatment administration options may be offered to patients on TB treatment: a Community- or home-based Directly Observed Therapy (DOT) is recommended over health facility-based DOT or unsupervised treatment
Recommended in favor
Conditional
Certainty of evidence
Moderate
Also Featured In
This recommendation also appears in the following guidelines:
Originally Developed
Guideline
Guidelines for treatment of drug-susceptible tuberculosis and patient care
Year2017
InstitutionWorld Health Organization
Guideline
WHO consolidated guidelines on tuberculosis: Module 4: Treatment - Drug-resistant tuberculosis treatment
Year2020
InstitutionWorld Health Organization
Guideline
WHO consolidated guidelines on tuberculosis: Module 4: treatment - drug-resistant tuberculosis treatment, 2022 update
Year2022
InstitutionWHO
Guideline
WHO consolidated guidelines on tuberculosis: module 4: treatment and care
Year2025
InstitutionWHO